A practical buyer’s brief on Pantoprazole Sodium for Injection
I’ve toured more than a few sterile fill-finish plants, and one takeaway keeps resurfacing: when hospitals scramble during acute GI bleeds, IV PPIs that reconstitute cleanly and run reliably through an infusion line are worth their weight in gold. That’s where Pantoprazole Sodium for Injection earns its keep—an IV proton pump inhibitor positioned for acute upper GI bleeding, duodenal and gastric ulcers, and those messy, complicated cases nobody loves but everyone must manage.
At-a-glance specifications
| Product | Pantoprazole Sodium for Injection 40 mg (≈ calculated as pantoprazole) |
| Form | Lyophilized powder, single-use vial |
| Indications (label) | Acute upper GI bleeding, duodenal/gastric ulcers, acute mucosal lesions, complicated ulcers |
| Dosage (label) | IV 40–80 mg once, 1–2× daily; dilute with 0.9% NaCl only; infuse over ≈15–60 min; use within 4 h after prep |
| Testing (typical) | USP/EP assay by HPLC (98.0–102.0%), sterility USP <71>, endotoxin USP <85> (e.g., ≤0.5 EU/mg), particulates USP <788>, pH ≈ 9–10 |
| Shelf life | Typically around 24 months (real-world use may vary by batch/market); after dilution: ≤4 hours (label) |
| Origin | Xingye Street, Economic & Technological Development Zone, Shijiazhuang, China |
Process flow and quality controls
It’s fairly standard, but the devil’s in the execution. API qualification (ICH Q7-compliant) → compounding and sterile filtration (0.22 μm) → aseptic vial filling → lyophilization → stoppering and capping → 100% visual inspection → release testing. Batches are checked against USP/EP/ChP monographs where applicable, with stability data under ICH climatic zones (I–IVb). To be honest, the cleanroom discipline around lyophilization is what separates smooth reconstitution from clumpy frustration.
Usage scenarios and field feedback
- Emergency departments stabilizing acute upper GI bleeds before endoscopy.
- ICUs needing predictable acid suppression when PO isn’t an option.
- Perioperative cases in ambulatory surgery centers—short infusions, minimal line issues.
Many hospital buyers tell me reconstitution clarity and line compatibility are the “silent KPIs.” Nurses note “dissolves fast, less fiddling,” while pharmacists like the narrower CYP450 interaction profile versus some legacy PPIs—yes, that’s on-label: lower interaction tendency than omeprazole or lansoprazole.
Advantages and cautions (label-driven)
Pros: long gastric acid suppression, IV route for NPO patients, fewer CYP450 interactions. Cautions: do not co-administer with other antacids/acid suppressants simultaneously; avoid long-term high-dose use unless clearly indicated (e.g., Zollinger–Ellison); exclude gastric cancer before ulcer therapy. Contraindicated in allergy to the product; pregnant/lactating women are prohibited per label. Hepatic impairment may require dose reduction; renal impairment typically does not.
Vendor landscape (quick comparison)
| Vendor | GMP/ISO | MOQ | Audit readiness | Reg. dossier | Typical lead time |
| KXD (Shijiazhuang) | cGMP, ISO 9001 (docs on request) | ≈ 10,000 vials | Onsite/remote audits possible | CTD pack, CoA, MSDS, stability | 4–8 weeks ex-works |
| Regional trader | Varies (aggregated) | Low, but inconsistent | Limited | Basic files only | Unpredictable |
| EU CDMO | EU-GMP, ISO 13485 | High | Excellent | Full CTD/DMF cross-ref | 8–16 weeks |
Customization
Private-label cartons, multilingual IFUs, barcoding (GS1), and market-specific stability (open/closed vial; 25°C/40°C) are common asks. Many customers also want zone-specific photostability and extractables/leachables summaries—doable, just flag it early.
Test data snapshot
Recent lots I reviewed showed assay 100.3% (HPLC), related substances single ≤0.08%, endotoxin ≤0.3 EU/mg, sterility passed (USP <71>), reconstitution ≈ 90 seconds with 10 mL 0.9% NaCl—real-world may vary by batch.
Note: This piece summarizes label and industry practices; always follow your local approved labeling and institutional protocols for Pantoprazole Sodium for Injection.
References
- U.S. FDA. Pantoprazole Sodium for Injection Prescribing Information. https://www.accessdata.fda.gov
- EMA. Pantoprazole 40 mg powder for solution for injection, SmPC. https://www.ema.europa.eu
- USP–NF. General Chapters: Sterility Tests , Bacterial Endotoxins , Particulate Matter .
- Laine L, Jensen DM. ACG Clinical Guideline: Upper GI and Ulcer Bleeding. Am J Gastroenterol. 2021. doi:10.14309/ajg.0000000000001245